Patent · US Active

γ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it

US7867996B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2009
Grant dateJan 11, 2011
Priority date
Expiry dateAug 27, 2029

Classification

  • Technology area (CPC H)Electricity
  • CPC primaryH04L51/212
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A γ-Crystalline form of ivabradine hydrochloride of formula (I):characterised by its powder X-ray diffraction data.Medicinal products containing the same which are useful as bradycardics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.